MediHope Medical Centre

11/10/2025

In a groundbreaking study, scientists have successfully used CRISPR gene editing to disable a liver gene responsible for raising bad cholesterol in the body. This innovative approach could offer a revolutionary way to combat high cholesterol and reduce the risk of heart disease, one of the leading causes of death worldwide.

The gene targeted by CRISPR plays a key role in regulating levels of low-density lipoprotein (LDL), commonly known as bad cholesterol. By turning off this gene, researchers were able to lower LDL levels dramatically in preclinical studies, without affecting other vital liver functions. This precise intervention could potentially replace lifelong cholesterol-lowering medications for some patients.

Experts say the technique demonstrates the growing potential of CRISPR as a tool for preventive medicine. Unlike traditional treatments that manage symptoms, this method tackles the problem at its genetic root, offering the promise of long-lasting cardiovascular protection.

While human trials are still needed to confirm safety and effectiveness, the discovery marks a major step forward in personalised medicine and gene therapy. It represents a future where heart disease could be prevented not just by diet and drugs, but by directly modifying the body’s genetic blueprint.

10/01/2025

Imagine a future without invasive treatments for skin cancer. A new cream could make it a reality.

Researchers at the University of Queensland are developing the world’s first skin cancer treatment cream, a revolutionary alternative to surgery and radiotherapy.

Designed primarily for organ transplant recipients, who are at a significantly higher risk of skin cancer due to immunosuppressive medications, the cream incorporates a unique drug that inhibits skin cancer formation.

The project, led by Associate Professor James Wells of the Frazer Institute, recently secured $344,000 in funding from the National Foundation for Medical Research and Innovation to support essential pre-clinical development.

This innovative treatment, developed in collaboration with UniQuest’s QEDDI small molecule drug discovery initiative, offers a first-of-its-kind solution to both prevent and treat early-stage skin cancers.

“This project funding is crucial for advancing the cream through pre-clinical development, enabling us to create a safe and effective formulation for human use,” said Dr. Wells. Currently, no FDA-approved treatments specifically target squamous cell carcinomas in transplant patients, leaving many to rely on surgeries or risk cancer progression.

The team aims to address this gap by ensuring the cream is rigorously tested for safety and efficacy, with the ultimate goal of clinical trials.

Learn more:
Source 1: https://www.uq.edu.au/news/article/2024/11/life-changing-cream-treat-skin-cancer-moves-closer-reality

Source 2: https://www.sciencedirect.com/science/article/abs/pii/S0169409X19301930

24/12/2024

09/12/2024

A groundbreaking stem cell procedure has reversed Type 1 diabetes in a woman in China, marking a major medical milestone:

Researchers used the woman’s own cells, reprogramming them into insulin-producing stem cells.

As a result, she began producing insulin naturally for the first time since developing the condition. This breakthrough offers new hope for millions with Type 1 diabetes, who currently depend on insulin therapy to manage their blood sugar levels.

The study involved three patients with Type 1 diabetes. Scientists extracted cells from each patient, converted them into stem cells capable of transforming into any cell type, and chemically reprogrammed them into insulin-producing cells.

These newly created cells were then placed inside the patients’ stomachs, where they began producing insulin. While it’s early days, the success with the first patient suggests a future where Type 1 diabetics may no longer need insulin injections to survive.

Learn more: https://www.emjreviews.com/diabetes/news/stem-cell-therapy-success-in-china-marks-milestone-in-type-1-diabetes-treatment/ #:~:text=Stem%2DCell%20Therapy%20Success%20in,in%20Type%201%20Diabetes%20Treatment&text=IN%20A%20GROUNDBREAKING%20medical%20achievement,reducing%20her%20reliance%20on%20injections.

17/10/2024

Scientists Removed HIV From Human Immune Cells Using CRISPR Gene Editing:

It prevented the virus from replicating and blocked reinfection.

Scientists at Temple University have used CRISPR/Cas9 gene editing to remove HIV-1 DNA from the genomes of human immune cells.

In lab experiments with patient-derived T-cells, the cleared cells remained resistant to HIV even after re-exposure, and the method was found to be safe with no toxic effects.

This breakthrough, published in Nature: Scientific Reports, builds on earlier studies where the team edited HIV DNA out of human cell lines but now demonstrates the technique’s effectiveness in real patient cells.

This research is a significant step toward a potential cure for HIV, as it offers a way to permanently eliminate the virus from infected cells rather than merely suppressing it with antiretroviral drugs.

Current treatments require lifelong adherence, and the virus can re-emerge if medication is stopped. The success of this gene-editing approach opens the door for new therapies that could eradicate HIV reservoirs in the body, marking a crucial development in the global fight against the virus.

28/06/2024

Child Health Week campaign at MediHope Kalingalinga by MOH. Bring your child for better future.

21/06/2024

29/04/2024

This Africa Vaccination Week, take your child for vaccination to the nearest health facility and help build immunity.

You are also encouraged to take vaccines that are for the other age groups like HPV to prevent cancer, the oral cholera vaccine or the COVID-19 vaccines among others.